Informações:
Falhas:
ID
31674
Descrição
Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy; ODM derived from: https://clinicaltrials.gov/show/NCT00638690
Link
https://clinicaltrials.gov/show/NCT00638690
Palavras-chave
Versões (1)
- 19/09/2018 19/09/2018 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
19 de setembro de 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Prostatic Neoplasms NCT00638690
Eligibility Prostatic Neoplasms NCT00638690
- StudyEvent: Eligibility
Similar models
Eligibility Prostatic Neoplasms NCT00638690
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Hormone refractory prostate cancer | Disease Progression metastatic | Status post Cytotoxic Chemotherapy Quantity
Item
metastatic castration-resistant prostate cancer progression after one or two prior cytotoxic chemotherapies
boolean
C1328504 (UMLS CUI [1])
C0242656 (UMLS CUI [2,1])
C1522484 (UMLS CUI [2,2])
C0231290 (UMLS CUI [3,1])
C0677881 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
C0242656 (UMLS CUI [2,1])
C1522484 (UMLS CUI [2,2])
C0231290 (UMLS CUI [3,1])
C0677881 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
Chemotherapy Quantity Containing Docetaxel
Item
at least one chemotherapy must have contained docetaxel
boolean
C0392920 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0332256 (UMLS CUI [1,3])
C0246415 (UMLS CUI [1,4])
C1265611 (UMLS CUI [1,2])
C0332256 (UMLS CUI [1,3])
C0246415 (UMLS CUI [1,4])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status <= 2
boolean
C1520224 (UMLS CUI [1])
Medical Castration | Male Castration | Testosterone measurement
Item
medical or surgical castration with testosterone < 50 ng/dl
boolean
C1513054 (UMLS CUI [1])
C0007347 (UMLS CUI [2])
C0523912 (UMLS CUI [3])
C0007347 (UMLS CUI [2])
C0523912 (UMLS CUI [3])
Bone Marrow function | Liver function | Renal function
Item
adequate bone marrow, hepatic and renal function
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
C0031843 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
Serum potassium measurement
Item
potassium >= 3.5 mmol/l
boolean
C0302353 (UMLS CUI [1])
Able to swallow Investigational New Drug Tablet
Item
able to swallow the study drug whole as a tablet
boolean
C2712086 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0039225 (UMLS CUI [1,3])
C0013230 (UMLS CUI [1,2])
C0039225 (UMLS CUI [1,3])
Informed Consent
Item
informed consent
boolean
C0021430 (UMLS CUI [1])
Cytotoxic Chemotherapy Quantity
Item
more than two prior cytotoxic chemotherapy regimens
boolean
C0677881 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,2])
Ketoconazole Prostate carcinoma
Item
prior ketoconazole for prostate cancer
boolean
C0022625 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
C0600139 (UMLS CUI [1,2])
Abiraterone acetate | CYP17 Inhibitor | Investigational New Drugs Targeting Androgen Receptor | Relationship Therapeutic procedure Prostate carcinoma
Item
prior abiraterone acetate or other cyp17 inhibitor or investigational agents targeting the androgen receptor for prostate cancer
boolean
C2607886 (UMLS CUI [1])
C3160096 (UMLS CUI [2])
C0013230 (UMLS CUI [3,1])
C1521840 (UMLS CUI [3,2])
C0034786 (UMLS CUI [3,3])
C0439849 (UMLS CUI [4,1])
C0087111 (UMLS CUI [4,2])
C0600139 (UMLS CUI [4,3])
C3160096 (UMLS CUI [2])
C0013230 (UMLS CUI [3,1])
C1521840 (UMLS CUI [3,2])
C0034786 (UMLS CUI [3,3])
C0439849 (UMLS CUI [4,1])
C0087111 (UMLS CUI [4,2])
C0600139 (UMLS CUI [4,3])
Uncontrolled hypertension
Item
uncontrolled hypertension
boolean
C1868885 (UMLS CUI [1])
Viral hepatitis | Viral hepatitis Symptomatic | Chronic liver disease
Item
active or symptomatic viral hepatitis or chronic liver disease
boolean
C0042721 (UMLS CUI [1])
C0042721 (UMLS CUI [2,1])
C0231220 (UMLS CUI [2,2])
C0341439 (UMLS CUI [3])
C0042721 (UMLS CUI [2,1])
C0231220 (UMLS CUI [2,2])
C0341439 (UMLS CUI [3])
Pituitary dysfunction | Dysfunction adrenal
Item
history of pituitary or adrenal dysfunction
boolean
C0281947 (UMLS CUI [1])
C0549609 (UMLS CUI [2])
C0549609 (UMLS CUI [2])
Heart Disease
Item
clinically significant heart disease
boolean
C0018799 (UMLS CUI [1])
Cancer Other
Item
other malignancy
boolean
C1707251 (UMLS CUI [1])
Metastatic malignant neoplasm to brain
Item
known brain metastasis
boolean
C0220650 (UMLS CUI [1])
Gastrointestinal Disease Affecting Absorption
Item
gi disorder affecting absorption
boolean
C0017178 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0237442 (UMLS CUI [1,3])
C0392760 (UMLS CUI [1,2])
C0237442 (UMLS CUI [1,3])
Contraceptive methods Unwilling
Item
not willing to use contraception
boolean
C0700589 (UMLS CUI [1,1])
C0558080 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,2])